Cargando…

Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study

AIM: To evaluate waiting list (WL) registration and liver transplantation (LT) rates in patients with hepatitis C virus (HCV)-related cirrhosis since the introduction of direct-acting antivirals (DAAs). METHODS: All adult patients with cirrhosis listed for LT at Padua University Hospital between 200...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferrarese, Alberto, Germani, Giacomo, Gambato, Martina, Russo, Francesco Paolo, Senzolo, Marco, Zanetto, Alberto, Shalaby, Sarah, Cillo, Umberto, Zanus, Giacomo, Angeli, Paolo, Burra, Patrizia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2018
Materias:	Observational Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6189844/ https://www.ncbi.nlm.nih.gov/pubmed/30344424 http://dx.doi.org/10.3748/wjg.v24.i38.4403

Ejemplares similares

Long-Term Impact of Direct-Acting Antivirals on Liver Fibrosis and Survival in HCV-Infected Liver Transplant Recipients
por: Gambato, Martina, et al.
Publicado: (2023)

The Role of Antiviral Prophylaxis in Preventing HBV and HDV Recurrence in the Setting of Liver Transplantation
por: Battistella, Sara, et al.
Publicado: (2023)

Neuropsychiatric performance and treatment of hepatitis C with direct-acting antivirals: a prospective study
por: Volpato, Sofia, et al.
Publicado: (2017)

Recent Advances in the Management of Acute Variceal Hemorrhage
por: Zanetto, Alberto, et al.
Publicado: (2021)

Hemodynamic Evaluation of Nonselective β-Blockers in Patients with Cirrhosis and Refractory Ascites
por: Ferrarese, Alberto, et al.
Publicado: (2018)

Management of bacterial infection in the liver transplant candidate
por: Ferrarese, Alberto, et al.
Publicado: (2018)

New Indications for Liver Transplantation
por: Zanetto, Alberto, et al.
Publicado: (2021)

Invasive fungal infection before and after liver transplantation
por: Ferrarese, Alberto, et al.
Publicado: (2020)

Nash Up, Virus Down: How the Waiting List Is Changing for Liver Transplantation: A Single Center Experience from Italy
por: Ferrarese, Alberto, et al.
Publicado: (2022)

Influence of Hepatocellular Carcinoma on Platelet Aggregation in Cirrhosis
por: Zanetto, Alberto, et al.
Publicado: (2021)

Liver transplantation for non-alcoholic fatty liver disease: indications and post-transplant management
por: Battistella, Sara, et al.
Publicado: (2023)

More Pronounced Hypercoagulable State and Hypofibrinolysis in Patients With Cirrhosis With Versus Without HCC
por: Zanetto, Alberto, et al.
Publicado: (2021)

Global hemostatic profiling in patients with decompensated cirrhosis and bacterial infections
por: Zanetto, Alberto, et al.
Publicado: (2022)

Toward a more precise prognostic stratification in acute decompensation of cirrhosis: The Padua model 2.0
por: Zanetto, Alberto, et al.
Publicado: (2023)

OC.04.8 IMPACT OF COVID-19 PANDEMIC ON REFERRAL OF PATIENTS WITH LIVER DISEASE TO A LIVER TRANSPLANT CENTER
por: Germani, G., et al.
Publicado: (2021)

Therapeutic approaches for portal biliopathy: A systematic review
por: Franceschet, Irene, et al.
Publicado: (2016)

Liver Transplantation for Alcoholic Liver Disease and Hepatocellular Carcinoma
por: Burra, Patrizia, et al.
Publicado: (2018)

Sex bias in clinical trials in gastroenterology and hepatology
por: Burra, Patrizia, et al.
Publicado: (2022)

Coagulopathy is not predictive of bleeding in patients with acute decompensation of cirrhosis and acute‐on‐chronic liver failure
por: Campello, Elena, et al.
Publicado: (2021)

COVID-19 and liver disease: where are we now?
por: Russo, Francesco Paolo, et al.
Publicado: (2022)

Reduced Clot Stability by Thromboelastography as a Potential Indicator of Procedure‐Related Bleeding in Decompensated Cirrhosis
por: Zanetto, Alberto, et al.
Publicado: (2020)

Management of Hepatocellular Carcinoma Recurrence after Liver Transplantation
por: Pelizzaro, Filippo, et al.
Publicado: (2021)

Recent advances in understanding and managing liver transplantation
por: Russo, Francesco Paolo, et al.
Publicado: (2016)

Cholangiocarcinoma as an Indication for Liver Transplantation in the Era of Transplant Oncology
por: Gringeri, Enrico, et al.
Publicado: (2020)

Impact of bacterial infections prior to liver transplantation on post-transplant outcomes in patients with cirrhosis
por: Incicco, Simone, et al.
Publicado: (2023)

Cancer-Associated Thrombosis in Cirrhotic Patients with Hepatocellular Carcinoma
por: Zanetto, Alberto, et al.
Publicado: (2018)

Molecular Refinement of Clinical Staging in Hepatocellular Carcinoma Patients Evaluated for Potentially Curative Therapies
por: Vitale, Alessandro, et al.
Publicado: (2011)

Hepatocellular Carcinoma in Chronic Viral Hepatitis: Where Do We Stand?
por: Russo, Francesco Paolo, et al.
Publicado: (2022)

NAFLD and liver transplantation: Disease burden, current management and future challenges
por: Burra, Patrizia, et al.
Publicado: (2020)

Diagnostic and prognostic performance of urinary neutrophil gelatinase‐associated lipocalin in patients with cirrhosis and acute kidney injury
por: Gambino, Carmine, et al.
Publicado: (2023)

Transplanting severely obese cirrhotic patients: Heavy clouds still on the horizon
por: Burra, Patrizia, et al.
Publicado: (2022)

Long term outcome of antiviral therapy in patients with hepatitis B associated decompensated cirrhosis
por: Ju, Young-Cheol, et al.
Publicado: (2018)

Clinical implications of COVID-19 in patients with chronic liver disease and liver tumor
por: Gambato, Martina, et al.
Publicado: (2020)

Advances and Controversies in Acute Alcohol-Related Hepatitis: From Medical Therapy to Liver Transplantation
por: Germani, Giacomo, et al.
Publicado: (2023)

Outcomes assessment of hepatitis C virus-positive psoriatic patients treated using pegylated interferon in combination with ribavirin compared to new Direct-Acting Antiviral agents
por: Damiani, Giovanni, et al.
Publicado: (2018)

Effect of treating chronic hepatitis C with direct-acting antivirals on extrahepatic cutaneous manifestations
por: El Kassas, Mohamed, et al.
Publicado: (2020)

Effectiveness and safety of generic and brand direct acting antivirals for treatment of chronic hepatitis C
por: Abdulla, Maheeba, et al.
Publicado: (2022)

Long term follow-up and outcome of liver transplantation from hepatitis B surface antigen positive donors
por: Ballarin, Roberto, et al.
Publicado: (2017)

Liver decompensation predicts ribavirin overexposure in hepatitis C virus patients treated with direct-acting antivirals
por: Guardigni, Viola, et al.
Publicado: (2017)

M2BPGi for assessing liver fibrosis in patients with hepatitis C treated with direct-acting antivirals
por: Saleh, Shereen A, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_s7evp5vv0i5p8a5jbdqg8bqg7r